GLP-1 Drugs vs Bariatric Surgery: What's Best for Weight Loss?

• Weight loss approaches are shifting from willpower to medical science with GLP-1 drugs and bariatric surgery.
• GLP-1 medications like Ozempic and Mounjaro encourage earlier intervention for weight loss.
• GLP-1 drugs are effective for overweight or Grade 1 obesity, mimicking gut hormones to suppress appetite.
• Bariatric surgery remains the gold standard for severe obesity (BMI 40+, or 35+ with comorbidities), offering predictable, long-term weight loss and health improvements.
• In India, bariatric surgery is often covered by insurance, while GLP-1 drugs can be a costly recurring expense; treatment should be personalized.

Key Questions Answered

How do GLP-1 drugs and bariatric surgery compare in long-term weight management?

Bariatric surgery is considered the gold standard for individuals with a BMI of 40 or higher, or 35 and above with comorbidities, as GLP-1 medications alone may not achieve sufficient or sustained wei

What are the financial implications of choosing GLP-1 medications versus surgery in India?

GLP-1 medications in India are now significantly more affordable following patent expiry, with monthly costs potentially ranging from ₹500 to ₹5,000, a substantial decrease from previo

When should individuals consider bariatric surgery over GLP-1 injections for obesity?

Individuals may consider bariatric surgery when GLP-1 injections are insufficient for their weight loss needs.